Oncology Institute (TOIIW) Assets (2019 - 2026)

Oncology Institute (TOIIW) has reported Assets for 8 consecutive years, with $168.2 million the latest figure, recorded in Q1 2026.

• Assets for Q1 2026 came in at $168.2 million, up 2.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $168.2 million (up 2.58% YoY), and the FY2025 annual result was $164.7 million, down 4.67% from the prior year.
• Assets was $168.2 million for Q1 2026 at Oncology Institute, up from $164.7 million in the prior quarter.
• Over five years, Assets peaked at $283.8 million in Q3 2022 and troughed at $159.8 million in Q2 2025.
• Average Assets over 5 years is $199.4 million, with a median of $189.7 million recorded in 2022.
• Year-over-year, Assets grew 28.62% in 2022 and declined 23.06% in 2023.
• Over 5 years, Assets stood at $261.7 million in 2022, then decreased by 20.04% to $209.2 million in 2023, then fell by 17.46% to $172.7 million in 2024, then dropped by 4.67% to $164.7 million in 2025, then advanced by 2.17% to $168.2 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $168.2 million in Q1 2026, $164.7 million in Q4 2025, and $163.6 million in Q3 2025.